The global market for transport protein assays kits is anticipated to grow at a CAGR of 12.3% from 2023 to 2031. To move molecules across the plasma membrane, transport proteins perform both active and passive transport functions. This is expected to boost the growth of the market for transport protein assay kits over the forecast period.
The global microcurrent facial market is anticipated to expand at a compound annual growth rate (CAGR) of 7.5% during the forecast period of 2023 and 2031. The increasing number of aesthetic professionals, the rising emphasis on anti-aging treatments, and the high influence of social media are anticipated to significantly drive market expansion. Non-invasive aesthetic procedures offer benefits such as less postoperative pain and surgical wounds, a shorter recovery period, rapid wound healing, smaller incisions, and fewer complications in comparison to invasive procedures.
Globally, the human capital management market is expected to grow with a CAGR of 8.5% during the forecast period from 2022 to 2030, starting from US$ 17.95 Bn in 2021. The market is driven by the increase demand among organizations to streamline the resource management, payroll, vendor management and other HR functions.
The 3D pedometer market worldwide is expected to grow at a CAGR of 5.5% during the forecast period from 2022 to 2030, starting from US$ 1.73 Bn in 2021. The demand for 3D pedometer is increasing rapidly due to rising fitness trackers market worldwide. Since 2020, the fitness trackers market is growing with over 10% growth rate annually. The multipurpose use of 3D pedometer to record various activities such as daily steps, distance covered, calories burned and others has propelled the penetration of 3D pedometers worldwide.
The life science instrumentation market is set to reach US$ 107,344.2 Mn by 2030 from US$ 68,336.6 Mn in 2021 showcasing moderate growth at a compounded annual growth rate (CAGR) of 6.5% during the forecast period from 2022 to 2030. Technological advancement in life science instruments and stringent healthcare norms pertaining to food and drug manufacturing processes drive market growth for life science instrumentation techniques.
Parkinson’s disease (PD), is progressive nervous system disorders, characterized by tremor, rigidity, bradykinesia, and postural instability. It is estimated that, the global Parkinson’s disease therapeutics market will show significant market growth over the forecast period from 2022 to 2030.
Companies in the life sciences are advancing in their adoption and use of digital and analytics. Yet, by heeding the lessons of recent years, they may move further and more quickly. Notwithstanding efforts over the past five years, life sciences businesses continue to lag cross-industry leaders in digital maturity by a ratio of two to three in every critical dimension—strategy, culture, organization, and capabilities—with no obvious signs of closing the gap.
Derisking drug discovery, speeding clinical trials, and reimagining engagement with HCPs are the greatest prospects that DnA could assist to realize. As a result, numerous industry leaders are adopting DnA into early-stage drug discovery and clinical development to shorten timeframes and increase the likelihood of success. In addition, market leaders are reimagining their connections with healthcare practitioners and patients in order to offer enhanced and individualized experiences and improve treatment outcomes.
The life sciences are progressively adopting cloud technology to accelerate tech-enabled business changes; by 2021, more than 80 percent of the top 20 global pharma and medtech enterprises will be cloud-based. In addition, businesses are increasingly utilizing the cloud to shift IT infrastructure management and to cover gaps in their software development and analytics skills by purchasing software as a service as opposed to building and maintaining it themselves.
Despite the widespread media interest, longer-term bets such as quantum technologies, Web3, and immersive reality account for just approximately 15% of life sciences technology investments. With a combination of Al and ML, cloud computing, quantum technologies, and bioengineering, for instance, life sciences firms may speed drug development, produce more tailored medicines, and optimize treatment regimens for patients.
Acute Market Reports is a market research and consulting company with a focus on the life sciences industry. Acute Market Reports' futuristic research model benefits our clients by enabling them to make timely, thoughtful business decisions. To deliver cutting-edge strategic research solutions to our international customers, we work with a wide range of industry participants.
